Common inflammatory bowel disease treatment blunts COVID-19 vaccine response, study finds
![Common inflammatory bowel disease treatment blunts COVID-19 vaccine response, study finds](https://crohnsfighters.com/wp-content/uploads/2023/02/scidaily-logo-rss.png)
People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of COVID-19 vaccine, after a large-scale study found many had poor antibody responses.